Silo Pharma Stock Investor Sentiment

SILO Stock  USD 1.36  0.02  1.45%   
About 62% of Silo Pharma's investor base is looking to short. The analysis of current outlook of investing in Silo Pharma suggests that many traders are alarmed regarding Silo Pharma's prospects. Silo Pharma's investing sentiment overview a quick insight into current market opportunities from investing in Silo Pharma. Many technical investors use Silo Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
over a year ago at finance.yahoo.com         
Silo Pharma Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD
Yahoo News
over a year ago at investing.com         
Silo Pharma advances PTSD treatment to clinical trial phase
Investing News at Macroaxis
over a year ago at finance.yahoo.com         
Silo Debuts New Bond Platform for the Masses
Yahoo News
over a year ago at finance.yahoo.com         
Silo Pharmas SP-26 Ketamine Implant Demonstrates Successful Drug Delivery
Yahoo News
over a year ago at globenewswire.com         
Silo Pharmas SP-26 Ketamine Implant Demonstrates Successful Drug Delivery
Macroaxis News: globenewswire.com
over a year ago at investing.com         
Silo Pharma advances ketamine-based chronic pain implant
Investing News at Macroaxis
over a year ago at screenrant.com         
Predicting Silo Season 2s Release Window After The Filming Update
news
over a year ago at screenrant.com         
Silo Season 2 Gets Major Filming Update From Rebecca Ferguson
news
over a year ago at news.google.com         
Silo Pharma announces roster of drugs in development for mental health, chronic pain - Healio
Google News at Macroaxis
over a year ago at news.google.com         
Silo Pharma Prioritizes Mental Health in 2024 Pipeline - TipRanks.com - TipRanks
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Ne...
Yahoo News
over a year ago at benzinga.com         
Psyched Suggestibility And Psychedelics Effects, EUs 7M Research Fund, Australias Treatment Delivery...
benzinga news
over a year ago at news.google.com         
Silo Pharma Inc Stock Is Down -0.71 percent This Week Buy, Hold, or Sell - InvestorsObserver
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Silo Launches the Worlds First Modern Bond Platform
Yahoo News
over a year ago at finance.yahoo.com         
Silo Pharma Announces Positive Results in Alzheimers Disease Study
Yahoo News
Far too much social signal, news, headlines, and media speculation about Silo Pharma that are available to investors today. That information is available publicly through Silo media outlets and privately through word of mouth or via Silo internal channels. However, regardless of the origin, that massive amount of Silo data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Silo Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Silo Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Silo Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Silo Pharma alpha.

Silo Pharma Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.15Dec2025Feb 020406080100120
JavaScript chart by amCharts 3.21.15Silo Pharma Silo Pharma Dividend Benchmark Dow Jones Industrial
       Timeline  

Other Information on Investing in Silo OTC Stock

Silo Pharma financial ratios help investors to determine whether Silo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Silo with respect to the benefits of owning Silo Pharma security.